Skip to main navigation
Skip to search
Skip to main content
Discovery - the University of Dundee Research Portal Home
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Search by expertise, name or affiliation
GSK3 inhibitors: Development and therapeutic potential
Philip Cohen
, Michel Goedert
Research output
:
Contribution to journal
›
Review article
›
peer-review
711
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'GSK3 inhibitors: Development and therapeutic potential'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glycogen Synthase kinase-3 Inhibitors
100%
Therapeutic Potential
100%
Inhibitor Development
100%
Glycogen Synthase Kinase 3 (GSK3)
66%
Cell Behavior
33%
Neurodegenerative Diseases
33%
Diabetes Disease
33%
Glycogen Metabolism
33%
Medicine and Dentistry
Glycogen Synthase Kinase 3 Inhibitor
100%
Glycogen Synthase Kinase 3
66%
Diabetes
33%
Cell Function
33%
Degenerative Disease
33%
Glycogen Metabolism
33%
Neuroscience
Glycogen Synthase Kinase 3 Inhibitor
100%
Glycogen Synthase Kinase 3
66%
Cell Function
33%
Metabolic Pathway
33%
Neurodegenerative Disorder
33%
Pharmacology, Toxicology and Pharmaceutical Science
Glycogen Synthase Kinase 3 Inhibitor
100%
Glycogen Synthase Kinase 3
66%
Degenerative Disease
33%
Biochemistry, Genetics and Molecular Biology
Glycogen Synthase Kinase 3
100%
Enzyme
20%
Cell Function
20%
Glycogen Metabolism
20%